.

.

.

.

THIS PAGE IS STILL VERY MUCH UNDER CONSTRUCTION.

FOR 3 VERY IN DEPTH STUDIES, SEE THESE 3 LINKS:

.

.

.

.

.

.

.

.

.

.

LLLT for inflammation of the middle eye, significantly effective, increased healing by 40% http://nt-cmb.medun.acad.bg:8080/jspui/handle/10861/297

http://www.sciencedirect.com/science/article/pii/S1567576909000617 -“phototherapy” very effective with neutrophils (white blood cells)

LLLT and LED for aging https://www.ncbi.nlm.nih.gov/pubmed/27363768

LLLT and LED for acne https://www.ncbi.nlm.nih.gov/pubmed/?term=%22lllt%22+%22LED%22+%22acne%22

LLLT for large variety of skin issues https://www.ncbi.nlm.nih.gov/pubmed/24049929

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126803/

  • LED which is a novel light source for non-thermal, non-ablative skin rejuvenation has been shown to be effective for improving wrinkles and skin laxity (Figure 3).3440It is not a new phenomenon since the first reports of LLLT effects on increased collagen go back to 1987. Studies by Abergel et al. and Yu et al. reported an increase in production of pro-collagen, collagen, basic fibroblast growth factors (bFGF) and proliferation of fibroblasts after exposure to low-energy laser irradiation in vitro and in vivo animal models (Figure 4).41,42

Mark every study with an * to show all that state no adverse effects reported

Biophasic dose response: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790317/

Eyes interesting: http://www.healingtheeye.com/Articles/Sunning_is_beneficial.html

carpal tunnel: http://online.liebertpub.com/doi/abs/10.1089/pho.2006.24.101

TN-NOT a study though http://cerebrabraintech.com/wp-content/uploads/2012/09/Low-Level%20Laser%20Therapy%20for%20Trigeminal%20Neuralgia.pdf

Vascular regeneration http://link.springer.com/article/10.1007/s10103-014-1699-9

Achilles tendinitis http://onlinelibrary.wiley.com/doi/10.1111/j.1751-1097.2011.00999.x/full

Improved muscle performance in elderly women https://www.ncbi.nlm.nih.gov/pubmed/27250715

Significant reduction in lung inflammation http://onlinelibrary.wiley.com/doi/10.1002/jbio.201500113/pdf

Ischemic brain injury, mice, BBB https://www.ncbi.nlm.nih.gov/pubmed/26889965

Hair regrowth https://www.ncbi.nlm.nih.gov/pubmed/25124964 and https://www.ncbi.nlm.nih.gov/pubmed/24078483

HairMax Comb: https://www.ncbi.nlm.nih.gov/pubmed/19366270

STUDIES

  • The first experimental FDA clearance of Class 3B Lasers occurred in February of 2002, after a successful study forcarpal tunnel syndrome on workers at General Motors. The laser that was used had a power of 90mw at 830nm.
    • References these:
      • Hurwitz, EL, Carragee EJ, vander Velde G, et al. Treatment of neck pain: noninvasive interventions: Results of the bone and joint decade 2000-2010 task Force on neck pain and its associated disorders. Spine 2008;33:S123-152.

Hopkins, JT, McLoda TA, Seegmiller JG, Baxter GD. Low-level laser therapy facilitates superficial wound healing in humans: A triple-blind, sham-controlled study. J Athl Train. 2004 Jul–Sep; 39(3): 223–229.

  • Proven Success
    • Studies:
      • Since 1967, thousands of studies have been conducted using various parameters of LLLT proving significant improvement with a wide variety of ailments. No serious adverse effects have ever been reported.
    • World Wide Usage
      • LLLT is used in over 70 countries.
      • Russia is the leader in LLLT.
      • Japan and Sweden are also top leaders in LLLT.
    • WALT-World Association of Laser Therapy
      • WALT is based out of Queensland, Australia and brings together those from all over the world who specialize in laser therapy. WALT showcases current research and serves to challenge current perspectives regarding laser therapy. WALT brings together industry professionals to discuss and share information on basic sciences, dental and oral health, clinical and novel applications in physiotherapy, pain management, tissue healing, cancer care and oncology, aesthetics, rehabilitation, veterinary practice and sports performance.
    • FDA
      • Low-Level Laser Therapy (LLLT) became FDA cleared in 2002 in the US after General Motors conducted a double blind study on 119 of their employees who developed carpal tunnel. The study was conducted in 1995 and used a Class IIIB laser with a frequency of 830nm. 72% of those who received LLLT were able to return to work, while only 41% of the placebo group was able to return to work, making the study statistically significant.
        • This study showed that physical therapy alone did improve grip strength, however significantly more subjects had improved grip strength and overall improvement when LLLT was added to their therapy.